Design Therapeutics (DSGN) Other Non Operating Income (2020 - 2024)

Design Therapeutics has reported Other Non Operating Income for 5 years, with the latest figure at $3.2 million in Q3 2024.

• Other Non Operating Income for Q3 2024 came in at $3.2 million, up 5.74% year-over-year; the trailing twelve-month figure through Sep 2024 was $13.0 million (up 29.01% YoY), and the FY2023 annual result was $11.3 million, up 164.36% from the prior year.
• Other Non Operating Income eased to $3.2 million in Q3 2024, from $3.2 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $3.3 million in Q1 2024 and troughed at -$40000.0 in Q1 2020.
• A 5-year average of $1.4 million and a median of $640000.0 in 2022 frame the typical range for Other Non Operating Income.
• The widest annual swing landed in 2021, when Other Non Operating Income plunged 69.84%; it then soared 7731.58% in 2022.
• A 5-year view of Other Non Operating Income shows it stood at $6000.0 in 2020, then jumped by 933.33% to $62000.0 in 2021, then surged by 3209.68% to $2.1 million in 2022, then jumped by 59.8% to $3.3 million in 2023, then dropped by 2.2% to $3.2 million in 2024.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $3.2 million in Q3 2024, $3.2 million in Q2 2024, and $3.3 million in Q1 2024.